A Feasibility Study of AI-Assisted Physiotherapy for Oral Cancer Patients
Starting soon · Not applicable
Conditions studied: AI (Artificial Intelligence), Oral Cancer
In brief
This study aims to evaluate the feasibility, safety, and acceptability of a newly developed artificial intelligence (AI)-assisted physiotherapy system for oromandibular and neck-shoulder range of motion (ROM) in patients who have undergone treatment for oral cancer. In this single-group, prospective, non-randomized pilot study, recruited participants will receive 4 to 6 weeks of AI-assisted physiotherapy. Participants will undergo a comprehensive clinical evaluation at baseline and post-intervention. During the intervention period, the AI system will perform a daily automated assessment to dynamically generate and adjust personalized exercise programs. Participants will perform these prescribed programs 3 to 4 times daily. Pre- and post-intervention changes, along with key feasibility parameters, acceptability, and safety metrics, will be statistically analyzed to inform future definitive trials.
Key facts
- Study ID
- NCT07635381
- Run by
- National Taiwan University Hospital
- People needed
- 15
- Starts
- 2026-07-27
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2026-07-20
Who can join
Age: 20 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Oral cancer patients with trismus, clinical signs of neck or shoulder joint impairment after oral cancer surgery or radiotherapy in recent 12 months
- Age between 20 and 70 years
You may not qualify if…
- Could not communicate
- Had any disorder that could influence movement performance (e.g., stroke, Parkinsonism, head injury)
Where it is running
- School and Graduate Institute of Physical Therapy, College of Medicine, National Taiwan University — Taipei, Taiwan
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.